Medication info

Lalavis Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Il Yang Biopharm Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201904541 · Approved 2019.07.03

This product's status changed to Expired on 2024.07.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
The usual dose, regardless of meals, is 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for concomitant therapy to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Il Yang Biopharm Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs.
View approved original text

This medication is used to treat gastrointestinal-related diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective in situations where inhibition of excessive gastric acid secretion is required, such as Zollinger-Ellison syndrome. It is used for the prevention and treatment of postoperative ulcers and for gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). When administered before anesthesia, it is given to prevent Mendelson's syndrome. It is effectively used for the treatment and prevention of various gastrointestinal disorders.

How to take

Adult dose

The usual dose, regardless of meals, is 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for concomitant therapy to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with impaired kidney function. It should also not be administered to patients with a history of allergic reactions to this drug or its components, acute porphyria, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and neonatal patients, as well as those on a potassium-restricted diet. Patients with liver dysfunction or a history of hypersensitivity to medication, elderly patients, those with a history of kidney impairment, and patients taking non-steroidal anti-inflammatory drugs should use this medication with caution. It may mask symptoms of gastric cancer; therefore, patients with gastric ulcers or middle-aged patients who recently developed or changed indigestion symptoms should confirm the absence of malignant diseases before using it. Patients with Helicobacter pylori infection and gastric or duodenal ulcers need eradication therapy, and caution is required for critically ill patients in intensive care units or those with hypophosphatemia, and those with swallowing difficulties. While taking this medication, severe allergic reactions such as anaphylactic shock may rarely occur, so if symptoms appear, dosing should be stopped immediately and medical staff informed. Administration should also cease if there are signs of hypersensitivity such as skin rash, hives, angioedema, fever, or difficulty breathing. Blood tests may reveal decreased white blood cells or platelets, liver function abnormalities, arrhythmias, gastrointestinal symptoms (nausea, vomiting, diarrhea, etc.), neurological symptoms (dizziness, drowsiness, confusion, etc.), muscle pain, or skin rashes; these should be discussed with healthcare providers as they arise. This medication should not be taken for long periods, and it is preferable to use the minimum effective dose while closely monitoring treatment progress. Elderly patients or those with chronic pulmonary disease, diabetes, or weakened immunity may be at an increased risk of pneumonia, so caution is advised. Furthermore, if dizziness or drowsiness occurs while taking this medication, avoid driving or operating hazardous machinery. This medication may interact with other drugs; if you are taking other medications, you must inform your healthcare provider, and dose adjustments or discontinuation may be necessary. Caution is particularly needed when used alongside certain anticoagulants, antibiotics, or antiepileptics. Pregnant or breastfeeding women are advised not to use this medication, and its safety and efficacy in children have not been fully established, so it is not recommended for them. This medication may cause false positive results in urine protein tests, so caution is required during testing, and in the case of overdose, appropriate emergency treatment such as vomiting or gastric lavage should be sought. Finally, this medication reduces gastric acid secretion, which may promote bacterial overgrowth in the gastrointestinal tract, necessitating eye examinations during prolonged use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum amino transferase
  • agranulocytosis
  • pancytopenia
  • bone marrow hypoplasia
  • aplastic anemia
  • refractory anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • disease sensation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that does not allow air to pass through, and it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.